REFERENCES
1 Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 1999 Jun 15;59(12):2776-80. PMID: 10383129.
2 Brodlie M, Barwick SC, Wood KM, McKean MC, Welch A. Inflammatory myofibroblastic tumours of the respiratory tract: paediatric case series with varying clinical presentations. J Laryngol Otol. 2011 Aug;125(8):865-8. doi: 10.1017/S0022215111000648. Epub 2011 Apr 12. PMID: 21481297
3 Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer 1973;31:191–208
4 Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol (2008) 61(4):428–37.10.1136/jcp.2007.049387
5 Höhne S, Milzsch M, Adams J, Kunze C, Finke R. Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-years-old child. Tumor (2015) 101:249–56.10.5301/tj.5000353]
6 Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. WHO Classification of Tumours of Soft Tissue and Bone. IARC; Lyon: 2013.
7 Donner LR, Trompler RA, White RR 4th. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol. 1996 Oct;27(10):1095-8. doi: 10.1016/s0046-8177(96)90291-9. PMID: 889259
8 Morotti RA, Legman MD, Kerkar N, Pawel BR, Sanger WG, Coffin CM. Pediatric inflammatory myofibroblastic tumor with late metastasis the lung: case report and review of the literature. Pediatr Dev Pathol 2005;8:224–9
9 Dishop MK, Kuruvilla S. Primaryand metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children’s hospital. Arch Pathol Lab Med 2008;132: 1079–10
10 Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM, Corradini N, Minard-Colin V, Zanetti I, Bisogno G, Gallego S, Merks JHM, De Salvo GL, Ferrari A. Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG). Eur J Cancer. 2020 Mar;127:123-129.
11 Zapatero J, Lago J, Madrigal L, Baschwitz B, Perez Rodriguez E, Penalver R, Candelas J. Subglottic inflammatory pseudotumor in a 6-year-old child. Pediatr Pulmonol. 1989;6(4):268-71. doi: 10.1002/ppul.1950060411. PMID: 2748224
12 Aijaz F, Salam AU, Muzaffar S, et al: Inflammatory pseudotumor of the trachea: Report of a case in an eight-year-old child. J Laryngology Otology 108:613-616, 1994
13 Storck M, Liewald F, Heymer B, et al: Inflammatory pseudotumor of the lung and trachea. Zentralbl Chir 120:650-656, 1995
14 Dewar AL, Connet GJ: Inflammatory Pseudotumor of the Trachea in a Ten-Month-Old Infant. Pediatr Pulmonol 23:307-309, 1997
15 BumberZ, JurlinaM, Manojlovic ̵́S, Jakic ̵́-RJ. Inflammatory pseudotumor of the trachea. J Pediatr Surg 2001; 36:631 – 634.
16 Chan PW, Omar KZ, Ramanujam TM. Successful treatment of unresectable inflammatory pseudotumor of the lung with COX-2 inhibitor. Pediatr Pulmonol  (2003) 36:167–9.10.1002/ppul.103
17 Hoseok I, Joungho H, Ahn KM, Lee SI, Jhingook K. Complete surgical resection of inflammatory myofibroblastic tumor with carinal reconstruction in a 4-year-old boy. J Pediatr Surg  (2005) 40:e23–5.10.1016/j.jpedsurg.2005.08.043
18 Sivanandan S, Lodha R, Agarwala S, Sharma M, Kabra SK. Inflammatory myofibroblastic tumor of the trachea. Pediatr Pulmonol  (2007) 42:847–50.10.1002/ppul.20651
19 Venizelos I, Papathomas T, Anagnostou E, Tsanakas J, Kirvassilis F, Kontzoglou G. Pediatric inflammatory myofibroblastic tumor of the trachea: a case report and review of the literature. Pediatr Pulmonol  (2008) 43:831–5.10.1002/ppul.20869
20 Breen DP, Dubus JC, Chetaille B, Payan MJ, Dutau H. A rare cause of an endobronchial tumour in children: the role of interventional bronchoscopy in the diagnosis and treatment of tumours while preserving anatomy and lung function. Respiration  (2008) 76:444–8.10.1159/000101718
21 Lizarbe MO, Olascoaga JH, García ER, Castiella TM, Sagaseta de Ilúrdoz Uranga María M, Garicano JM. Paediatric myofibroblastic tumours. A presentation of three cases. An Pediatr (Barc)  (2009) 71:331–5.10.1016/j.anpedi.2009.06.010
22 Ochs K, Hoksch B, Frey U, Schmid RA. Inflammatory myofibroblastic tumour of the lung in a five-year-old girl. Interact Cardiovasc Thorac Surg  (2010) 10:805–6.10.1510/icvts.2009.219089
23 Sacco O, Gambini C, Gardella C, Tomà P, Rossi UG, Jassoni V, et al. “Atypical steroid response” in a pulmonary: inflammatory myofibroblastic tumor. Pediatr Pulmonol  (2010) 45:721–6.10.1002/ppul.21237
24 Brodlie M, Barwick SC, Wood KM, McKean MC, Welch A. Inflammatory myofibroblastic tumours of the respiratory tract: paediatric case series with varying clinical presentations. J Laryngol Otol (2011) 125:865–8.10.1017/S0022215111000648
25 El-Desoky T, Nasef N, Osman E, Osman A, Zaki A, Zalata K. Endobronchial inflammatory pseudotumor: a rare cause of a pneumothorax in children. J Bronchology Interv Pulmonol  (2013) 20:256–60.10.1097/LBR.0b013e31829bccba
26 Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 14
27 Mossé YP, Voss SD, Lim MS, et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol. 2017;35(28):3215-3221. doi:10.1200/JCO.2017.73.4830
28 Mossé YP Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies.
Clin Cancer Res. 2016 Feb 1; 22(3):546-52
29 Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD, Shapiro GI. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med.
30 Mosse’ YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study Lancet Oncol, 14 (2013), pp. 472-480
31 Sufliarsky, H.A. Gelderblom, et al. Prospective, non-randomized, multicenter, phase 2 trial of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumor with and without anaplastic lymphoma kinase gene alterations: EORTC study 90101 CREATE Lancet Respiratory Medicine, 6 (2018), pp. 431-441).
32 Brivio E, C.M. Zwaan ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: efficacy and side effects Pediatr Blood Cancer, 66 (5) (2019 May)
33 Craig E, Wiltsie Laura M, Lynda K. Beaupin, Ayesha Baig, Rafalkozielski David, H. Rothstein, Veetail Li, Clare J.Twistm Matthew Barth Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review, Journal of Pediatric Surgery , Feb 2021
34 Siminovich M, Galluzzo L, López J, Lubieniecki F, de Dávila MT. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation. Pediatr Dev Pathol. 2012 May-Jun;15(3):179-86. doi: 10.2350/11-10-1105-OA.1. Epub 2012 Jan 26. PMID: 22280150.)
35 Antonescu CM, Suurmeijer A. JH, Zhang L,Sung YS, Jungbluth AA, Travis WD, Al-Ahmadie H,, Fletcher C, Alaggio R.Molecular Characterization of Inflammatory Myofibroblastic Tumors with Frequent ALK and ROS1 Fusions and Rare Novel RET Gene Rearrangement. Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404. PMID: 25723109; PMCID: PMC4465992.
36 Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, Coffin CM) Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014 Aug; 4(8):889-95